Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease

Epstein Barr virus (EBV)(+) Hodgkin's disease (HD) expresses clearly identified tumor antigens derived from the virus and could, in principle, be a target for adoptive immunotherapy with viral antigen–specific T cells. However, like most tumor-associated antigens in immunocompetent hosts, these...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bollard, Catherine M., Aguilar, Laura, Straathof, Karin C., Gahn, Benedikt, Huls, M. Helen, Rousseau, Alexandra, Sixbey, John, Gresik, M. Victoria, Carrum, George, Hudson, Melissa, Dilloo, Dagmar, Gee, Adrian, Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Rockefeller University Press 2004
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2211993/
https://ncbi.nlm.nih.gov/pubmed/15611290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20040890
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi